Condensed Consolidated Statements of Stockholders Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2020	$ 274,282	$ 3	$ 315,288	$ 33	$ (41,042)
Beginning balance, shares at Dec. 31, 2020		32,485,784
Issuance of common stock upon exercise of common stock options and vesting of restricted stock units	70		70
Issuance of common stock upon exercise of common stock options and vesting of restricted stock units, Shares		64,527
Proceeds from follow-on public offering, net of underwriters' discounts and commissions and issuance costs	96,762	$ 1	96,761
Proceeds from follow-on public offering, net of underwriters' discounts and commissions and issuance costs, Shares		4,600,000
Stock-based compensation	974		974
Unrealized (loss) gain on available-for-sale securities	(5)			(5)
Net loss	(8,866)				(8,866)
Ending balance at Mar. 31, 2021	363,217	$ 4	413,093	28	(49,908)
Ending balance, shares at Mar. 31, 2021		37,150,311
Beginning balance at Dec. 31, 2020	274,282	$ 3	315,288	33	(41,042)
Beginning balance, shares at Dec. 31, 2020		32,485,784
Unrealized (loss) gain on available-for-sale securities	4
Net loss	(22,840)
Ending balance at Jun. 30, 2021	350,709	$ 4	414,550	37	(63,882)
Ending balance, shares at Jun. 30, 2021		37,251,771
Beginning balance at Mar. 31, 2021	363,217	$ 4	413,093	28	(49,908)
Beginning balance, shares at Mar. 31, 2021		37,150,311
Issuance of common stock upon exercise of common stock options	119		119
Issuance of common stock upon exercise of common stock options, shares		85,593
Issuance of common stock under employee stock purchase plan	229		229
Issuance of common stock under employee stock purchase plan, shares		15,867
Stock-based compensation	1,109		1,109
Unrealized (loss) gain on available-for-sale securities	9			9
Net loss	(13,974)				(13,974)
Ending balance at Jun. 30, 2021	350,709	$ 4	414,550	37	(63,882)
Ending balance, shares at Jun. 30, 2021		37,251,771
Beginning balance at Dec. 31, 2021	321,084	$ 4	417,363	(388)	(95,895)
Beginning balance, shares at Dec. 31, 2021		37,379,077
Issuance of common stock upon exercise of common stock options	210		210
Issuance of common stock upon exercise of common stock options, shares		244,981
Stock-based compensation	2,731		2,731
Unrealized (loss) gain on available-for-sale securities	(1,068)			(1,068)
Net loss	(20,980)				(20,980)
Ending balance at Mar. 31, 2022	301,977	$ 4	420,304	(1,456)	(116,875)
Ending balance, shares at Mar. 31, 2022		37,624,058
Beginning balance at Dec. 31, 2021	$ 321,084	$ 4	417,363	(388)	(95,895)
Beginning balance, shares at Dec. 31, 2021		37,379,077
Issuance of common stock upon exercise of common stock options, shares	288,457
Unrealized (loss) gain on available-for-sale securities	$ (1,537)
Net loss	(45,315)
Ending balance at Jun. 30, 2022	280,565	$ 4	423,696	(1,925)	(141,210)
Ending balance, shares at Jun. 30, 2022		37,817,724
Beginning balance at Mar. 31, 2022	301,977	$ 4	420,304	(1,456)	(116,875)
Beginning balance, shares at Mar. 31, 2022		37,624,058
Issuance of common stock upon exercise of common stock options and vesting of restricted stock units	83		83
Issuance of common stock upon exercise of common stock options and vesting of restricted stock units, Shares		163,387
Issuance of common stock under employee stock purchase plan	214		214
Issuance of common stock under employee stock purchase plan, shares		30,279
Stock-based compensation	3,095		3,095
Unrealized (loss) gain on available-for-sale securities	(469)			(469)
Net loss	(24,335)				(24,335)
Ending balance at Jun. 30, 2022	$ 280,565	$ 4	$ 423,696	$ (1,925)	$ (141,210)
Ending balance, shares at Jun. 30, 2022		37,817,724